Early-onset spastic ataxia, myoclonic epilepsy, neuropathy syndrome (disorder) | | Early-onset spastic ataxia, myoclonic epilepsy, neuropathy syndrome | | Autosomal recessive spastic ataxia type 5 AFG3L2 (AFG3 like matrix AAA peptidase subunit 2) related spastic ataxia, myoclonic epilepsy, neuropathy syndrome AFG3L2-related spastic ataxia, myoclonic epilepsy, neuropathy syndrome
| | A rare hereditary spastic ataxia disorder with childhood onset of slowly progressive lower limb spastic paraparesis and cerebellar ataxia (with dysarthria, swallowing difficulties, motor degeneration), associated with sensorimotor neuropathy (including muscle weakness and distal amyotrophy in lower extremities) and progressive myoclonic epilepsy. Ocular signs (ptosis, oculomotor apraxia), dysmetria, dysdiadochokinesia, dystonic movements and myoclonus may also be associated. Caused by homozygous mutation in the AFG3L2 gene on chromosome 18p11. | | syndroom van vroeg optredende spastische ataxie, myoklonische epilepsie en neuropathie | | syndroom van AFG3L2-geassocieerde spastische ataxie, myoklonische epilepsie en neuropathie SPAX5 autosomaal recessieve spastische ataxie type 5 syndroom van vroeg optredende spastische ataxie, myoclonusepilepsie en neuropathie
|
| Id | 771469002 | Status | Primitive |
DHD Diagnosis thesaurus reference set |
ICD-10 complex map reference set | Target | G11.4 | Rule | TRUE | Advice | ALWAYS G11.4 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION | Correlation | SNOMED CT source code to target map code correlation not specified |
Target | G40.3 | Rule | TRUE | Advice | ALWAYS G40.3 | Correlation | SNOMED CT source code to target map code correlation not specified |
Target | G60.0 | Rule | TRUE | Advice | ALWAYS G60.0 | Correlation | SNOMED CT source code to target map code correlation not specified |
|
|